Detalhe da pesquisa
1.
The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study.
BMC Gastroenterol
; 21(1): 268, 2021 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34182924
2.
Clinically Significant Fibrosis Is Associated With Longitudinal Increases in Fibrosis-4 and Nonalcoholic Fatty Liver Disease Fibrosis Scores.
Clin Gastroenterol Hepatol
; 18(3): 710-718.e4, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31352092
3.
Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control.
J Diabetes Complications
; 32(8): 799-804, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29861312
4.
Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management.
Medicine (Baltimore)
; 96(26): e6761, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28658094
5.
A review of the clinical utility of the Enhanced Liver Fibrosis test in multiple aetiologies of chronic liver disease.
Ann Clin Biochem
; 57(1): 36-43, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31529981